Recursion Pharmaceuticals (RXRX) Debt Ratio (2020 - 2026)

Recursion Pharmaceuticals has reported Debt Ratio for 7 years, with the latest figure at 0.01 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio fell 35.98% year-over-year to 0.01; the trailing twelve-month figure through Mar 2026 stood at 0.01 (down 35.98% YoY), and the FY2025 full-year result was 0.01, down 33.21% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.01, down from 0.01 in the prior quarter.
• The five-year high for Debt Ratio was 0.04 in Q2 2024, with the low at 0.0 in Q4 2022.
• Historically, Debt Ratio has averaged 0.01 across 5 years, with a median of 0.0 in 2024.
• Annual changes were most pronounced in 2022 — Debt Ratio tumbled 97.82% — and 2024, when it jumped 2208.58%.
• Recursion Pharmaceuticals' Debt Ratio stood at 0.0 in 2022, then soared by 128.57% to 0.0 in 2023, then surged by 984.57% to 0.02 in 2024, then slumped by 33.21% to 0.01 in 2025, then decreased by 2.98% to 0.01 in 2026.
• The last three Debt Ratio figures came in at 0.01 (Q1 2026), 0.01 (Q4 2025), and 0.01 (Q3 2025), per Business Quant data.